Prompt.ly is a technology company.
Prompt.ly has raised $2.0M across 1 funding round.
Prompt.ly has raised $2.0M in total across 1 funding round.
Promptly refers to multiple technology companies, with the most prominent being Promptly Health (promptlyhealth.com), a global provider of end-to-end Real-World Evidence (RWE) solutions that connect healthcare organizations, life sciences companies, and AI firms to derive insights from high-quality clinical datasets while ensuring privacy via federated data infrastructure[1][5]. It serves healthcare providers, payers, hospitals, and pharma companies across Europe, LatAm, and Asia, solving the challenge of securely sharing, augmenting, and monetizing sensitive patient data (e.g., clinical, socio-economic, claims data plus patient-reported outcomes) through pay-per-access models, enabling better healthcare decisions at lower costs for thousands of patients daily[1][5]. Another key player is TryPromptly (trypromptly.com), a no-code generative AI platform for enterprises to build custom AI agents, apps, and chatbots by chaining models from providers like OpenAI and integrating proprietary data sources (e.g., PDFs, URLs, audio), targeting businesses needing scalable, secure AI with features like self-hosted vector DBs and SOC 2 Type II compliance[2][8].
These companies demonstrate strong growth: Promptly Health boasts 100+ global implementations across 30+ clinical areas, partnerships with top life sciences firms, EU insurers, and hospitals in 6 countries, supported by a 50+ team of MDs, engineers, and data experts[1][5]; TryPromptly emphasizes enterprise-scale features like APIs, org analytics, and data sharing for production-ready AI[2].
Promptly Health emerged as a builder of the first patient-centered global evidence network, focusing on harmonized real-world datasets augmented with patient-generated data, though specific founding year, founders, or early traction details are not detailed in available sources—its evolution centers on expanding from Europe/LatAm to Asia with MSAs from top payers and hospitals, achieving 100+ implementations[1][5]. The idea likely stemmed from the need to enable secure, scalable RWE generation amid rising demand for privacy-preserving health data analytics.
TryPromptly positions itself as an enterprise AI builder without explicit founder backstory, but its platform evolution highlights rapid feature additions like RAG pipelines, multi-model support (OpenAI, Cohere, etc.), and no-code data imports, gaining trust from enterprise teams via modular prototyping to production[2]. Other "Promptly" entities, like Promptly Check-In (patient engagement software) and Promptly AI (multi-tool AI platform), appear as niche players without deep origin details, focusing on healthcare automation and content tools respectively[3][4][6].
Promptly Health rides the real-world evidence boom in healthcare, fueled by AI-driven analytics needs for drug development, payer decisions, and personalized medicine—timing aligns with post-pandemic data privacy regs (e.g., GDPR) and federated learning advances, enabling global networks without data silos while market forces like rising healthcare costs favor its monetization model[1][5]. It influences the ecosystem by partnering with life sciences/AI firms, promoting cost-effective care via insights from 30+ conditions.
TryPromptly taps the enterprise generative AI wave, addressing customization gaps in tools like ChatGPT via no-code builders amid $100B+ AI market growth; its timing leverages maturing LLMs and RAG tech, with security features countering enterprise adoption barriers, positioning it to democratize AI app dev and boost internal ops/productivity[2][8]. Collectively, these Promptlys highlight AI's healthcare pivot—health data/AI platforms reduce inefficiencies, with federated/no-code trends accelerating scalable, compliant innovation.
For Promptly Health, expansion into AI-augmented RWE (e.g., digital biomarkers) and more regions will drive growth, shaped by AI-health convergence and value-based care trends—its network could evolve into a dominant evidence marketplace, amplifying influence on global pharma trials[1][5]. TryPromptly eyes deeper enterprise penetration via advanced agents/multi-modal data, riding agentic AI and custom LLM fine-tuning waves, potentially becoming a go-to for secure, no-code AI scaling[2].
As emerging AI-health intersect players, Promptlys exemplify how federated data and no-code tools unlock insights and efficiency, tying back to their core mission of connecting organizations with actionable, private tech for real-world impact.
Prompt.ly has raised $2.0M in total across 1 funding round.
Prompt.ly's investors include AiSprouts VC, Andreessen Horowitz, LOI Venture, SOSV, David Hauser, Yee Lee.
Prompt.ly has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in November 2013.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2013 | $2.0M Seed | AiSprouts VC, Andreessen Horowitz, LOI Venture, SOSV, David Hauser, Yee Lee |